Latest News

New therapeutic target for Huntington's disease

Research has revealed a possible new target for treating movement disorders such as Huntington's disease and Parkinson's disease. A scientist has found a definite improvement in motor behaviors in a Huntington's disease mouse model when one of the major neurotransmitters in the brain, called Metabotropic Glutamate Receptor 5 was deleted.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Sensors used to monitor dangerous hits on football field

  • 'Abandoned' stroke survivors need better longer-term care, expert says

  • Black Republicans put most faith in US government

  • Bedside caregivers: Research shows opening visitation access improves patient satisfaction

  • Expectant mothers with epilepsy face tough choices over their medication

  • Possible cause of common dementia found, opening avenues for treatment

  • Lou Gehrig's disease study: Renewing brain's aging support cells may help neurons survive

  • Minutes in Criminal Procedures: Writing Style Influences Judges

  • Greater inequality within UK, USA than some developing countries, trade 'footprint' shows

  • Even mild depressive symptoms result in poorer lumbar spinal stenosis surgery outcome

  •